Phase 1 Dose Escalation of ArtemiCoffee

NCT04805333 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Artemisia annua 450mg
DRUG: Artemisia annua 900mg
DRUG: Artemisia annua 1350mg
DRUG: Artemisia annua 1800mg
DRUG: Artemisia annua - recommended phase II dose

Sponsor

Frederick R. Ueland, M.D.

Collaborators

[object Object]